Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2012, Article ID 952359, 4 pages
http://dx.doi.org/10.1155/2012/952359
Case Report

Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels

1Section of Hepatology, Rush University Medical Center, Chicago, IL 60612, USA
2Section of Pathology, Rush University Medical Center, Chicago, IL 60612, USA

Received 26 April 2012; Accepted 20 June 2012

Academic Editors: S. Faenza, R. L. Heilman, and R. Zhang

Copyright © 2012 Christopher M. Moore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. F. Murray and R. L. Carithers, “AASLD practice guidelines: evaluation of the patient for liver transplantation,” Hepatology, vol. 41, no. 6, pp. 1407–1432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. V. R. Dharnidharka, A. H. Tejani, P. L. Ho, and W. E. Harmon, “Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk,” American Journal of Transplantation, vol. 2, no. 10, pp. 993–998, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. G. Koch, L. Christiansen, J. Lazarchick, R. Stuart, I. R. Willner, and A. Reuben, “Posttransplantation lymphoproliferative disorder—the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus,” Liver Transplantation, vol. 13, no. 6, pp. 904–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. T. V. Cacciarelli, M. Green, R. Jaffe et al., “Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy,” Transplantation, vol. 66, no. 8, pp. 1047–1052, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. W. K. Kremers, H. C. Devarbhavi, R. H. Wiesner, R. A. F. Krom, W. R. Macon, and T. M. Habermann, “Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival,” American Journal of Transplantation, vol. 6, no. 5, part 1, pp. 1017–1024, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Kim, S. H. Yun, H. K. Chun, W. Y. Lee, and Y. B. Cho, “Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: report of a case,” Surgery Today, vol. 39, no. 12, pp. 1076–1079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. M. Ghobrial, T. M. Habermann, M. J. Maurer et al., “Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7574–7582, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. P. Nelson, M. A. Nalesnik, D. W. Bahler, J. Locker, J. J. Fung, and S. H. Swerdlow, “Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?” American Journal of Surgical Pathology, vol. 24, no. 3, pp. 375–385, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Silva, P. S. Jambulingam, and D. F. Mirza, “Colorectal cancer after orthotopic liver transplantation,” Critical Reviews in Oncology/Hematology, vol. 56, no. 1, pp. 147–153, 2005. View at Publisher · View at Google Scholar · View at Scopus